Evidence item

The primary study reports adjusted effectiveness estimates for moderate and severe rotavirus gastroenteritis. MEASUREMENT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 19440

Source: Effectiveness of the oral rotavirus vaccine ROTASIIL among children hospitalized with acute gastroenteritis in India · locator {} · excerpt hash sha256:ce0e09fdd97e5887b12015e8372a62364126a4cc7129da679321e71a3770e101

The aVE against moderate RVGE was 56% (CI, 11-79), and that of severe RVGE was 54% (CI, 31-70). The highest genotype-specific aVE was 62% (CI, 29-80) against G1P[8].